PPARG and urinary bladder cancer: Interestingly, similar results were reported with a decrease in anti-apoptotic protein (Bcl-2) and an increase in pro-apoptotic protein (caspase 3) on human bladder cancer 5637 and T24 cell lines with the treatment of more than 10 μM concentration of rosiglitazone with PPAR-γ expression [96].